500
Participants
Start Date
November 29, 2021
Primary Completion Date
February 13, 2023
Study Completion Date
March 23, 2023
NNC0480-0389
A weekly dose of NNC0480-0389, dose increased in each cohort. The study will last for about 41weeks.
Semaglutide
A weekly dose of semaglutide, same dose in each cohort. The study will last for about 41weeks.
Placebo (NNC080-0389)
A weekly dose of placebo (NNC0480-0389). The study will last for about 41weeks.
Placebo (semaglutide)
A weekly dose of placebo (semaglutide). The study will last for about 41weeks.
Clinexpert Egészségügyi Szolgáltató és Kereskedelmi Kft., Budapest
Bajcsy-Zsilinszky Kórház, Budapest
MED-TIMA Kft., Budapest
MH Egészségügyi Központ, Budapest
UMHAT Aleksandrovska, Sofia
Medical centre - Doverie AD, Sofia
UMHAT Sofiamed, Sofia
Hvidovre Hospital Endokrinologisk forsknings afsnit 159, Hvidovre
IPMC - Dr. Elizabeta Dimitrova, Petrich
Center for Klinisk Metabolisk Forskning, Hellerup
"Medical centre Zdrave 1 OOD", Kozloduy
Debreceni Egyetem Belgyógyászati Klinika, Debrecen
Debreceni Egyetem Klinikai Központ Belgyógyászati Klinika D épület, Debrecen
"Prevencia-2000-MCOC", Stara Zagora
Kaposi Mór Oktató Kórház, Kaposvár
PTE-AOK II. Belgyogyaszati Klinika es Nephrologiai Centrum, Pécs
Aarhus Universitetshospital Diabetes og Hormonsygdomme, Aarhus N
Vas Vármegyei Markusovszky Egyetemi Oktatókórház, Szombathely
Endocrinology, Diabetes and Metabolism Diseases Clinic, Belgrade
"Laiko General Hospital of Athens", Athens
Alexandra General Hospital, Therapeutic Clinic, Athens
AMC Community Endocrinology, Albany
University Hospital of Athens ATTIKON, Athens
Iatriko Athinon (Athens Medical Canter), Athens
Iatriko Athinon 'Palaiou Falirou', Athens
PharmQuest Life Sciences LLC, Greensboro
University of North Carolina, Chapel Hill
Physicians East Endocrinology, Greenville
Piedmont Healthcare/Research, Statesville
Progressive Medical Research, Port Orange
Northeast Research Institute, Jacksonville
South Broward Research LLC, Miramar
Reyes Clinical Research, Inc, Miami
Clinical Centre Kragujevac, Internal Diseases Clinic, Endocrinology department, Kragujevac
Clinical Centre Kragujevac, Internal Diseases Clinic, Endocr, Kragujevac
Headlands Research - Sarasota, Sarasota
The Research Group of Lexington LLC, Lexington
Advanced Med Res Maumee, Maumee
Arcturus HC PLC Troy Med Res, Troy
Iowa Diabetes & Endo Res Ctr, West Des Moines
EUROMEDICA Gen Clinic The/ki, Endocrin,Metabolism,Diabetes, Thessaloniki
"Thermi Private Hosital", Thessaloniki
Mercury Str Med Grp, PLLC, Butte
Cedar-Crosse Research Center, Chicago
Essential Medical Research LLC, Tulsa
Velocity Clinical Res-Dallas, Dallas
Quality Research Inc, San Antonio
VIP Trials_San Antonio, San Antonio
Consano Clinical Research, LLC, Shavano Park
Solaris Clinical Research, Meridian
Velocity Clin Res Los Angeles, Los Angeles
Torrance Clin Res Inst, Inc., Lomita
San Fernando Valley Hlth Inst, LLC, Canoga Park
Valley Clinical Trials, Inc., Northridge
Velocity Clin Res-Chula Vista, Chula Vista
Velocity Clinical Research San Diego, La Mesa
Headlands Research California, LLC, Escondido
Artemis Institute for Clin Res, San Diego
Artemis Insitute for Clin Res, Riverside
Providence Medical Foundation, Fullerton
First Valley Med Grp Lancaster, Lancaster
Medinet LLC, Saint Petersburg
Penza Regional Clinical Hospital named after N.N. Burdenko, Penza
Tumen State Medical University, Tyumen
LLC RC Medical, Novosibirsk
Brigham & Women's Hospital, Boston
UT Southwestern Med Cntr, Dallas
Naka Kinen Clinic_Internal medicine, Ibaraki
Yoshimura clinic, Kumamoto
Kansai Electric Power Hospital_Center for Diabetes, Osaka
Tokyo Center Clinic, Tokyo
ToCROM Clinic, Tokyo
Higashi-shinjuku clinic, Tokyo
NZOZ Vita-Diabetica Malgorzata Buraczyk, Bialystok
Krakowskie Centrum Medyczne Sp. z o.o., Krakow
Centrum Terapii Współczesnej J.M. Jasnorzewska S.K.A., Lodz
FutureMeds Sp. z o.o. Lodz, Lodz
Osrodek Badan Klinicznych Clinsante, Torun
Centrum Medyczne AMED Warszawa, Warsaw
Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych I Administracji, Warsaw
FutureMeds Sp. z o.o., Wroclaw
SPSK nr 1 im. prof. Stanisława Szyszko Śląskiego Uniwersytetu Medycznego w Katowicach, ul. 3-go Maja 13/15 41-800 Zabrze, Zabrze
Velocity Nova Sp. z o.o., Staszów
Lead Sponsor
Novo Nordisk A/S
INDUSTRY